Litcius/Paper detail

Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer

Kshitija Abhang, Sayali Dighe, Oly Katari, Vivek R. Yadav, Sanyog Jain

2025Drug Delivery and Translational Research7 citationsDOI

Topics & Concepts

ProdrugOxaliplatinTriple-negative breast cancerBreast cancerPharmacologySAFERMedicineAlbuminCancer researchChemistryCancerInternal medicineColorectal cancerComputer scienceComputer securityMetal complexes synthesis and propertiesNanoparticle-Based Drug DeliveryProtein Interaction Studies and Fluorescence Analysis
Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer | Litcius